Waiting
Traitement de la connexion…

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Comprehensive Protocol to Sample and Process Bone …
JoVE Journal
Cancer Research

Ce contenu est en libre accès.

JoVE Journal Cancer Research
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
 

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Article DOI: 10.3791/56386-v • 09:57 min • March 5th, 2018
March 5th, 2018 •
*1,2, *3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2,4, 1, 3, 1
1Department of Hematology, VU University Medical Center, 2Pediatric Oncology/Hematology, VU University Medical Center, 3Janssen Research & Development, LLC, 4Princess Máxima Center for Pediatric Oncology
* These authors contributed equally

Chapitres

résumé
Automatic Translation

Detection of minimal or measurable residual disease (MRD) is an important prognostic biomarker for refining risk assessment and predicting relapse in acute myeloid leukemia (AML). These comprehensive guidelines and recommendations with best practices for consistent and accurate identification and detection of MRD, may aid in making effective AML treatment decisions.

Tags

Keywords: Bone Marrow Acute Myeloid Leukemia Measurable Residual Disease Leukemia Stem Cells Sampling Processing Protocol Hematology Diagnosis Treatment Monitoring
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter